Innate immunity of the ocular surface

Brain Research Bulletin

Volumn 81, Issue 2-3, 2010, Pages 219-228

  Ueta, Mayumi ^a,b   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

Epithelium; Inflammation; Innate immunity; Ocular surface; Toll like receptors (TLRs)

Indexed keywords

DOUBLE STRANDED RNA; FLAGELLIN; I KAPPA B; I KAPPA B ZETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG; VIRUS RNA;

BULLOUS SKIN DISEASE; CLINICAL FEATURE; CONJUNCTIVA EPITHELIUM; CONJUNCTIVITIS; CORNEA DISEASE; CORNEA EPITHELIUM; DISEASE ASSOCIATION; EPITHELIUM CELL; EYE INFLAMMATION; GRAM NEGATIVE BACTERIUM; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE; MACROPHAGE; MICROORGANISM DETECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SKIN DEFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VIRUS INFECTION;

ANIMALS; BACTERIA; EPITHELIAL CELLS; EPITHELIUM; HUMANS; IMMUNITY, INNATE; INFLAMMATION; TOLL-LIKE RECEPTORS;

EID: 73149107224     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.10.001     Document Type: Review

References (27)

1. Akira S. Toll-like receptor signaling. J. Biol. Chem. 278 (2003) 38105-38108
2. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8 (2008) 458-466
3. Hozono Y., Ueta M., Hamuro J., Kojima K., Kawasaki S., Yamazaki K., et al. Human corneal epithelial cells respond to ocular-pathogenic, but not to nonpathogenic-flagellin. Biochem. Biophys. Res. Commun. 347 (2006) 238-247
4. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18 (2000) 621-663
5. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 (2008) 591-597
6. Kojima K., Ueta M., Hamuro J., Hozono Y., Kawasaki S., Yokoi N., et al. Human conjunctival epithelial cells express functional Toll-like receptor 5. Br. J. Ophthalmol. 92 (2008) 411-416
7. Matsumoto M., Kikkawa S., Kohase M., Miyake K., and Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293 (2002) 1364-1369
8. Methods 1. Immunohistochemistry of TLR2,3,4,5 in Human Cornea Sections and Conjunctival Sections. Human corneal tissues were obtained from corneal buttons of a patient undergoing corneal transplantation for early-stage bullous keratopathy and human conjunctival tissues were obtained at conjunctivochalasis surgery. Serial sections (6 μm) were prepared and slides were fixed with methanol for 30 min. And then, slides were incubated with purified mouse anti-human TLR2 (TL2.1) or 3 (TLR3.7) or 4 (HTA125) monoclonal antibody (mAb; eBioscience, San Diego, CA) or TLR5 monoclonal antibody (mAb; Abcam, Cambridge, UK), or isotype control mouse IgG2a for TLR2,4,5, or mouse IgG1 for TLR3 (DakoCytomation, Kyoto, Japan) at 4 °C in a moist chamber overnight. After the slides were washed in PBS-, Alexa Fluor 488 donkey anti-mouse IgG (H+L) (Molecular Probes, Eugene, OR) was applied for 1 h at room temperature. After the slides were washed, they were mounted with antifade mounting medium with PI (Vectashield; Vector Laboratories, Burlingame, CA).
9. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
10. Sotozono C., Inagaki K., Fujita A., Koizumi N., Sano Y., Inatomi T., et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea 21 (2002) S94-101
11. Sotozono C., Ang L.P., Koizumi N., Higashihara H., Ueta M., Inatomi T., et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology 114 (2007) 1294-1302
12. Sotozono C., Ueta M., Koizumi N., Inatomi T., Shirakata Y., Ikezawa Z., et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116 (2009) 685-690
13. Uematsu S., and Akira S. Toll-like receptors and Type I interferons. J. Biol. Chem. 282 (2007) 15319-15323
14. Ueta M. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea 27 Suppl. 1 (2008) S31-40
15. Ueta M., Nochi T., Jang M.H., Park E.J., Igarashi O., Hino A., et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J. Immunol. 173 (2004) 3337-3347
16. Ueta M., Hamuro J., Kiyono H., and Kinoshita S. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem. Biophys. Res. Commun. 331 (2005) 285-294
17. Ueta M., Hamuro J., Yamamoto M., Kaseda K., Akira S., and Kinoshita S. Spontaneous ocular surface inflammation and goblet cell disappearance in I kappa B zeta gene-disrupted mice. Invest. Ophthalmol. Vis. Sci. 46 (2005) 579-588
18. Ueta M., Iida T., Sakamoto M., Sotozono C., Takahashi J., Kojima K., et al. Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface. J. Med. Microbiol. 56 (2007) 77-82
19. Ueta M., Sotozono C., Inatomi T., Kojima K., Tashiro K., Hamuro J., et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br. J. Ophthalmol. 91 (2007) 962-965
20. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., and Kinoshita S. Association of IL4R polymorphisms with Stevens-Johnson syndrome. J. Allergy Clin. Immunol. 120 (2007) 1457-1459
21. Ueta M., Hamuro J., Ueda E., Katoh N., Yamamoto M., Takeda K., et al. Stat6-independent tissue inflammation occurs selectively on the ocular surface and perioral skin of IkappaBzeta-/- mice. Invest. Ophthalmol. Vis. Sci. 49 (2008) 3387-3394
22. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., and Kinoshita S. Association of Fas ligand gene polymorphism with Stevens-Johnson syndrome. Br. J. Ophthalmol. 92 (2008) 989-991
23. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., and Kinoshita S. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications. Invest. Ophthalmol. Vis. Sci. 49 (2008) 1809-1813
24. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430 (2004) 218-222
25. Yamane Y., Aihara M., and Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol. Int. 56 (2007) 419-425
26. Yamazaki S., Muta T., and Takeshige K. A novel IkappaB protein. IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276 (2001) 27657-27662
27. Yetiv J.Z., Bianchine J.R., and Owen Jr. J.A. Etiologic factors of the Stevens-Johnson syndrome. South Med. J. 73 (1980) 599-602